Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
VERICEL CORPORATION (VCEL), most recent 12 months reported: revenue $324.17M, net income $33.31M, free cash flow $57.89M. Latest balance sheet on file: liquid cash $170.27M. From SEC filings. More on VERICEL CORPORATION: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): Immunocore Holdings plc · NOVAVAX, INC. · MeiraGTx Holdings plc · IOVANCE BIOTHERAPEUTICS, INC. · Vir Biotechnology, Inc. · ADAPTIVE BIOTECHNOLOGIES CORPORATION · Vaxart, Inc. · Alector, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.